drugset / Trial / NCT00004038

Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer

NCT00004038

Phase 1 Completed 20 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of gene therapy plus chemotherapy in treating patients who have breast cancer. Inserting the p53 gene into a person's cancer cells may improve the body's ability to fight cancer or make the cancer more sensitive to chemotherapy. Combining chemotherapy with gene therapy may kill more tumor cells.

Timeline

Start
1999-01
Primary completion
2001-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject CONTUSUGENE LADENOVEC Unknown Other

Indications